Differential expression of MHC class II molecules by microglia and neoplastic astroglia: Relevance for the escape of astrocytoma cells from immune surveillance

Neuropathology and Applied Neurobiology

Volumn 24, Issue 4, 1998, Pages 293-301

  Tran, C T ^a   Wolz, P ^a   Egensperger, R ^b   Kosel S ^a   Imai, Y ^c   Bise, K ^a   Kohsaka, S ^c   Mehraein, P ^a   Graeber, M B ^d  

^a UNIVERSITY OF MUNICH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^d MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

Author keywords

Antigen presentation; BB1 B7 costimulator; Brain macrophages; Immunotherapy; T cell anergy

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; ASTROCYTOMA; CANCER GRADING; CELL POPULATION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOREACTIVITY; MACROGLIA; MACROPHAGE; MICROGLIA; PRIORITY JOURNAL;

ANTIGEN PRESENTATION; ASTROCYTES; BIOPSY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOTHERAPY; MACROPHAGES; PARAFFIN EMBEDDING; T-LYMPHOCYTES;

EID: 0031866813     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.1998.00120.x     Document Type: Article

References (41)

1. Bernstein JJ. Local invasion and intraparenchymal metastasis of astrocytomas. Neuropathol Appl Neurobiol 1996; 22: 421-4
2. Bo L, Mørk S, Kong PA, Nyland H, Pardo CA, Trapp BD. Detection of MHC class II antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 1994; 51: 135-46
3. Boyle EA, McGeer PL. Cellular immune response in multiple sclerosis plaques. Am J Pathol 1990; 137: 575-84
4. Burger PC, Scheithauer BW. Tumours of the Central Nervous System. Atlas of Tumour Pathology (Third Series, Fascicle 10). Armed Forces Institute of Pathology, Washington, D.C., 1994
5. Chaux P, Martin MS, Martin F. T-Cell co-stimulation by the CD28 ligand B7 is involved in the immune response leading to rejection of a spontaneously regressive tumour. Int J Cancer 1996; 66: 244-8
6. Dangond F, Windhagen A, Groves CJ, Hailer DA. Constitutive expression of costimulatory molecules by human microglia and its relevance to CNS autoimmunity. J Neuroimmunol 1997; 76: 132-8
7. De Simone R, Giampaolo A, Giometto B et al. The costimulatory molecule 157 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropathol Exp Neurol 1995; 54: 175-87
8. Egensperger R, Kösel S, Schnabel R, Mehraein P, Graeber MB. Apolipoprotein E genotype and neuropathological phenotype in two members of a German family with chromosome 14-linked early onset Alzheimer's disease. Acta Neuropathol 1995; 90: 257-65
9. Frank E, De Tribolet N. Immunobiology of brain tumours. Neurosurg Rev 1986; 9: 31-7
10. Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A. Antigen presentation and tumour cytotoxicity by interferon-gamma-treated microglial cells. Eur J Immunol 1987; 17: 1271-8
11. Gimmi CD, Freeman GJ, Gribben JG, Gray G, Nadler LM. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci USA 1993; 90: 6586-90
12. Graeber MB, Bise K, Mehraein P. CR3/43, a marker for activated human microglia: Application to diagnostic neuropathology. Neuropathol Appl Neurobiol 1994; 20: 406-8
13. Graeber MB, Streit WJ. Microglia: immune network in the CNS. Brain Pathol 1990; 1: 2-5
14. Gratas C, Tohma Y, Vanmeir EG et al. Fas ligand expression in glioblastoma cell-lines and primary astrocytic brain-tumours. Brain Pathol 1997; 7: 863-9
15. Imai Y, Ibata I, Ito D, Ohsawa K, Kohsaka S. A novel gene iba1 in the major histocompalibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 1996; 224: 855-62
16. Jaeckle KA. Immunotherapy of malignant gliomas. Sem Oncol 1994; 21: 249-59
17. Kida S, Ellison DW, Steart PV, Weller RO. Characterization of perivascular cells in astrocytic tumours and peritumoural oedematous brain. Neuropathol Appl Neurobiol 1995; 21: 121-9
18. Kleihues P, Burger PC, Scheithauer BW. Histological Typing of Tumours of the Central Nervous System. World Health Organization International Histological Classification of Tumours. Berlin: Springer Verlag, 1993
19. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996; 19: 312-8
20. Kreutzberg GW, Blakemore WF, Graeber MB. Cellular pathology of the central nervous system. In: Greenfield's Neuropathology, 6th Edn. Eds Graham, D.I. & Lantos, P.L., London: Edward Arnold, 1997: 85-156.
21. Lee SC, Raine CS. Multiple sclerosis: oligodendrocytes in active lesions do not express class II major histocompatibility complex molecules. J Neuroimmunol 1989; 25: 261-6
22. Mondino A, Jenkins MK. Surface proteins involved in T cell costimulation. J Leukocyte Biol 1994; 55: 805-15
23. Mannoji H, Yeger H, Becker LE. A specific histochemical marker (lectin Ricinus communis agglutinin-1) for normal human microglia, and application to routine histopathology. Acta Neuropathol 1986; 71: 341-3
24. Morimura T, Neuchrist C, Kitz K et al. Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumour proliferation. Acta Neuropathol 1990; 80: 287-94
25. Oyaizu N, Adachi Y, Hashimoto F et al. Monocytes express Fas ligand upon CD4 cross-linking and induce CD4 (+) T cell apoptosis: A possible mechanism of bystander cell-death in HIV infection. J Immunol 1997; 158: 2456-63
26. Passlick B, Izbicki JR, Simmel S et al. Expression of major histocompatibility class 1 and class II antigens and intercellular adhesion molecule-1 on operable non-small cell lung carcinomas: frequency and prognostic significance. Eur J Cancer 1994; 30A: 376-81
27. Paulus W, Roggendorf W, Kirchner T. Ki-M1P as a marker for microglia and brain macrophages in routinely processed human tissues. Acta Neuropathol 1992; 84: 538-44
28. Penfield W. Microglia and the process of phagocytosis in gliomas. Am J Pathol 1925; 1: 77-97
29. Roggendorf W, Strupp S, Paulus W. Distribution and characterization of microglia/macrophages in human brain tumours. Acta Neuropathol 1996; 92: 288-93
30. Rossi ML, Hughes JT, Esiri MM, Coakham HB, Brownell DB. Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol 1987; 74: 269-77
31. Rossi ML, Cruz-Sanchez F, Hughes JT, Esiri MM, Coakham HB, Moss TH. Mononuclear cell infiltrate and HLA-DR expression in low grade astrocytomas. An immunohistological study of 23 cases. Acta Neuropathol 1988; 76: 281-6
32. Rossi ML, Esiri MM, Jones NR et al. Characterization of the mononuclear cell infiltrate and HLA-Dr expression in 19 oligodendrogliomas. Surg Neurol 1991; 36: 119-25
33. Rossi ML, Jones NR, Karr GF, Esiri MM, Havas L, Coakham HB. HLA-Dr expression by tumour cells compared with survival in high grade astrocytomas. Tumori 1991; 77: 122-5
34. Schneider J, Hofman FM, Apuzzo ML, Hinton DR. Cytokines and immunoregulatory molecules in malignant glial neoplasms. J Neurosurg 1992; 77: 265-73
35. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990; 248: 1349-56
36. Streit WJ, Kincaid-Colton CA. The brain's immune system. Sci Am 1995; 273: 54-61
37. Sutter A, Hekmat A, Luckenbach GA. Antibody-mediated tumour cytotoxicity of microglia. Pathobiology 1991; 59: 254-8
38. Teh M, Wee A, Raju GC. HLA-DR antigen expression in colonic adenomas and adenocarcinomas. Pathology 1994; 26: 123-6
39. Von Eitzen U, Egensperger R, Kösel S et al. Microglia and the development of spongiform change in Creutzfeldt-Jakob disease. J Neuropathol Exp Neurol 1998; 57: 246-56
40. Watanabe K, Tachibana O, Yonekawa Y, Kleihues P, Ohgaki H. Role of gemistocytes in astrocytoma progression. Lab Invest 1997; 76: 277-84
41. Williams K, Ulvestad E, Antel JP. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur J Immunol 1994; 24: 3031-7